Systemic Lupus Erythematosus (SLE) Phase 2 SunStone trial, a multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of obexelimab in patients with SLE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback